Boston Scientific Corporation is paying to resolve remaining pelvic mesh lawsuits in 47 states plus the District of Columbia, bringing long-running product safety litigation closer to a final resolution.
The $188.7m settlement was announced on 23 March and did not involve any admission of guilt or responsibility on the part of Boston Scientific
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?